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mystery of how the correct and incorrect
expression of telomerase is linked to the
development ofcancer.
The first group to describe the gene was
headed by Toru Nakamura and included
Nobel Prize winner Thomas Cech of
Colorado University at Boulder and the
Howard Hughes Medical Institute, as well
as six additional authors, five of whom
work for Geron Corporation of Menlo
Park, California. Their findings were pub-
lished in the 15 August 1997 issue of
Science. "We hope the cloning of this gene
will lead to the discovery and use of new
drugs in the fight against cancer," said Greg
Morin ofGeron, one ofthe coauthors.
In the 22 August 1997 issue of Cell a
second group, led by Matthew Meyerson of
the Massachusetts Institute of Technology
(MIT), announced their discovery of the
same gene. The group also included Robert
Weinberg of the Whitehead Institute of
biomedical Kesearch
at MIT and eleven
others.
Jerry Shay, a pro-
fessor of cell biology
and neurosciences at
University of Texas
Southwestern Medical
Center in Dallas and a
recognized leader in
telomerase research,
said of the simultane-
ous cloning of this
gene, "This is impor-
tant because we can
now begin to under-
stand how telomerase
works. Ifwe can't find
a cure for cancer, we
need to start detecting
it earlier so we can
stop it-or control
it-before it spreads.
Telomerase can be
used as an early defini-
tive marker ofcancer."
Also newsworthy
is the way in which
the telomerase gene
was cloned. "It should
have taken a couple of
years to clone," said
Shay, "but because the
Human Genome
Project clones ESTs
[expressed sequence
tags] the groups were
able to pick it out
through its homology to the yeast telom-
erase gene." An EST is a 400- or 500-base-
pair fragment that is identified through
random sequencing ofcDNA libraries. The
groups were able to look at these ESTs and
identify those that showed homology, or
identical sequence, with the already identi-
fied yeast telomerase gene. Therefore, the
work ofthe Human Genome Project accel-
erated by years the cloning and identifica-
tion ofan unknown gene.
"This is all early, basic, science-type
stuff. We are a long way from being able to
extend life and cure cancer," said Shay.
"But these are profound things to even be
contemplating."
A New Reason Not to Smoke
New evidence provides support for the
argument that smoking may cause cervical
cancer, not just in smokers but also in non-
smoking women who are exposed to envi-
ronmental cigarette smoke. The study,
reported in the 18 June 1997 issue of the
A question of cancer. New evidence shows
that environmental tobacco smoke may have
serious health effects for women including a
strong linkto cervical cancer.
Journal of the National
Cancer Institute, is the
first to find a tobacco-
specific carcinogen in
samples of cervical
mucus taken from both
smoking and nonsmok-
ing women. The car-
cinogen is 4-(methyl-
nitrosamino) 1 -l(3-
pyridyl)-1-butanone
(NNK), an N-nitro-
samine that is formed
during the processing
and burning of tobacco
products. NNK is one
of the most potent
carcinogens found in
tobacco smoke. It has
been detected in the
sidestream smoke ofcig-
arettes (the smoke that
wafts from a smoldering
cigarette), which means
that not only smokers
but also nonsmokers
who breathe in sec-
ondary cigarette smoke
are exposed to NNK.
The study was con-
ducted by Bogdan
Prokopczyk, head of the
section of bio-organic
chemistry in the division
of cancer etiology and
prevention at theAmerican
Health Foundation in
Valhalla, New York, and
Steven E. Waggoner, an assistant professor
of gynecologic oncology at the University
ofChicago Medical Center, and colleagues.
The study cohort consisted of 25 women,
15 ofwhom smoked and 10 ofwhom did
not smoke. The women were aged 18-45,
were free ofany active genital tract disease,
and were not currently using oral contra-
ceptives. The scientists collected cervical
mucus samples from the women and used
highly sensitive gas chromatography-mass
spectrometry analyses to identify and quan-
tify the NNK in the samples. Of 26 sam-
ples taken (one woman gave two samples),
only one-taken from one of the non-
smoking women-did not contain some
measurable amount of NNK. Among the
other 9 nonsmokers, NNK concentrations
ranged from 4.1 to 30.8 nanograms per
gram (ng/g) of mucus, approximately one-
third lower than the amounts found in the
samples taken from the smokers, which
ranged from 11.9 to 115.0 ng/g.
Scientists have known for some time
that there is a link between cigarette smoke
and cervical cancer, but the precise nature
of the link is still uncertain. Prior research
has determined that noncarcinogenic com-
pounds from cigarette smoke, such as nico-
tine and its metabolite cotinine, can be
detected in the cervical mucus. There is
also evidence that cigarette smoke is capa-
ble of causing damage to DNA in cervical
epithelial tissue. But the new findings are
the first time that a carcinogen specific to
tobacco has been found in the cervical
mucus of women who smoke. The link
between smoking and cervical cancer has
been greatly strengthened by these latest
findings, which, according to the report's
authors, lend "biologic plausibility in sup-
port of the association between cigarette
smoking and [cervical cancer]."
In the United States in 1996, there
were an estimated 15,700 new cases ofcer-
vical cancer and 4,900 deaths from the dis-
ease. According the JNCI study, cervical
cancer is the top cause ofdeath from cancer
in women in developing countries, and is
one of the most common cancers among
U.S. women aged 15-54. The foremost
risk factor for cervical cancer is infection
with certain strains of the human papillo-
mavirus (HPV). The DNA-level effects of
such viruses are found in up to 93% ofall
examined cervical tumors, but these effects
alone are not thought to be enough to
induce carcinogenesis. Many other factors
are associated with cervical cancer, includ-
ing deficiencies in micronutrients such as
beta carotene and folate, impaired immune
status, early onset of sexual activity, and
cigarette smoking.
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